Search results
FDA approves Eli Lilly's treatment which slows symptoms down
Daily Mail· 7 days agoMade by Indianapolis-based Eli Lilly, donanemab is a monoclonal antibody treatment designed to slow...
Eli Lilly Remains an Equities Outlier
FX Empire via Yahoo Finance UK· 4 days agoIt’s no wonder LLY shares are up 54% this year – and they could rise more. MAPsignals data shows how Big Money investors are betting heavily on the...
I visited the Cottingham micropub with the not-so-micro name
Hull Live via Yahoo News UK· 2 days ago-Credit: (Image: Hull Live) It's a microbar with a not-so-micro name. Given its full title, The Hugh...
New Drug Approved for Early Alzheimer’s
New York Times· 7 days agoThe drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the...
2 Reasons Why Age Is Now A Critical People Strategy
Forbes· 1 day agoAge is at the forefront of business people strategy for two primary reasons: a shrinking talent pipeline, and workplace discrimination that has led to...
'Game-changing' Alzheimer's drug is approved in US - as UK decision imminent
The Sun· 6 days agoDonanemab, sold in the US under the brand name Kisunla, will be available for patients with early...
Mounjaro leads to significantly more weight loss than Ozempic, study suggests
CNN.com· 11 hours agoPeople taking tirzepatide injections lost more weight and were more likely to reach specific weight...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease | CNN
CNN.com· 6 days agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
CNN via Yahoo News UK· 6 days agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance UK· 4 days agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...